Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Premenopausal Breast Cancer”

164 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 164 results

Not applicableStudy completedNCT02154139
What this trial is testing

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Who this might be right for
Breast Cancer
Takeda 651
Large-scale testing (Phase 3)UnknownNCT01622361
What this trial is testing

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 290
Testing effectiveness (Phase 2)UnknownNCT00080756
What this trial is testing

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
City of Hope Medical Center 11
Not applicableUnknownNCT05800197
What this trial is testing

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

Who this might be right for
Breast CancerNeoadjuvant Endocrine Therapy
Blokhin's Russian Cancer Research Center 300
Large-scale testing (Phase 3)Study completedNCT00293540
What this trial is testing

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 249
Not applicableLooking for participantsNCT05010356
What this trial is testing

Insulin Sensitivity After Breast Cancer

Who this might be right for
Insulin Sensitivity/ResistanceBreast CancerSurvivorship+1 more
University of Copenhagen 24
Large-scale testing (Phase 3)Study completedNCT00201851
What this trial is testing

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 740
Large-scale testing (Phase 3)UnknownNCT04753177
What this trial is testing

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Who this might be right for
The Neoadjuvant Therapy
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Not applicableLooking for participantsNCT05910294
What this trial is testing

Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Who this might be right for
Improve Sexual HealthImprove Vulvovaginal Health
Memorial Sloan Kettering Cancer Center 50
Not applicableUnknownNCT03383835
What this trial is testing

Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Lauren Nye 11
Not applicableStudy completedNCT07127315
What this trial is testing

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Not applicableUnknownNCT03543059
What this trial is testing

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Sun Yat-sen University 2,000
Not applicableStudy completedNCT01588834
What this trial is testing

Histology of Functional Density in Premenopausal Breast

Who this might be right for
Dense BreastsBreast Cancer
Mayo Clinic 23
Testing effectiveness (Phase 2)Study completedNCT03481998
What this trial is testing

SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 104
Not applicableNot Yet RecruitingNCT07833501
What this trial is testing

Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast Cancer
D'Or Institute for Research and Education 172
Testing effectiveness (Phase 2)Ended earlyNCT02990845
What this trial is testing

Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Premenopausal Breast Cancer
National Taiwan University Hospital 16
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Not applicableStudy completedNCT01649661
What this trial is testing

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Who this might be right for
Cancer Free Women
Memorial Sloan Kettering Cancer Center 437
Testing effectiveness (Phase 2)UnknownNCT02592746
What this trial is testing

Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Who this might be right for
Metastatic Breast Cancer
Samsung Medical Center 182
Next Page